MIPS and Thermo Fisher announce ‘GPCR Cryo-EM and Drug Design’ collaboration
A new collaboration between MIPS researcher Professor Patrick Sexton’s team and the leading biological cryo-EM biotechnology product development company, Thermo Fisher Scientific, will bring cryo-electron microscopy of G protein-coupled
Old fashioned may be the safest bet: Monash researchers find that paracetamol works best for pain relief
Research by the Centre for Medicine Use and Safety at Monash University in collaboration with the Department of Emergency Medicine, Auckland Hospital in New Zealand has found that paracetamol alone is just as effective as combining opioids and
MIPS maintains top score in 2018 ERA rankings
The Monash Institute of Pharmaceutical Sciences has again received excellent results in the latest Excellence in Research for Australia (ERA) rankings.
Technology based on Monash research licensed by PureTech Health to Boehringer Ingelheim
Collaboration will use technology licensed to PureTech Health to develop Boehringer Ingelheim’s novel immuno-oncology product candidates
US biopharmaceutical company licenses Monash University 'superbug' drug discovery
Monash University announced today the grant of an exclusive licence of its portfolio of proprietary synthetic polymyxin antibiotics to Qpex Biopharma, a US-based biopharmaceutical company focused on developing new antibiotics to combat the
Breakthrough could lead to better drugs to tackle diabetes and obesity
Breakthrough research at Monash University has shown how different areas of major diabetes and obesity drug targets can be ‘activated’, guiding future drug development and better treatment of diseases.
Medicine & health
From lab to industry, Monash-linked start up attracts $7M investment
Drug discovery research at Monash has underpinned a new spin out company to develop therapies for metabolic syndrome and type-2 diabetes-related diseases.
Medicine & health
Monash led study of 1000+ heavy smokers reveals an undiagnosed burden of COPD
Chronic obstructive pulmonary disease (COPD) is the fifth leading cause of death in Australia, with 7.5% of Australians over the age of 40 years experiencing moderate to severe forms of the disease. Smoking is the main cause of COPD, with as many
Faculty success in major Commonwealth grant programs
The Monash Faculty of Pharmacy and Pharmaceutical Sciences has been awarded nearly $20 million dollars in research funding in the recent rounds of grants announced by the National Health and Medical Research Council (“NHMRC”) and the